Citation: Ca. Peloquin et Se. Berning, ADVICE ON TREATMENT OF DRUG-RESISTANT TUBERCULOSIS, American journal of health-system pharmacy, 54(6), 1997, pp. 700-701
Citation: Ca. Peloquin et Se. Berning, ADVICE ON TREATMENT OF MYCOBACTERIUM-AVIUM COMPLEX INFECTION, American journal of health-system pharmacy, 54(10), 1997, pp. 1208-1209
Citation: Gw. Amsden et al., THE ROLE OF ADVANCED GENERATION MACROLIDES IN THE PROPHYLAXIS AND TREATMENT OF MYCOBACTERIUM-AVIUM COMPLEX (MAC) INFECTIONS, Drugs, 54(1), 1997, pp. 69-80
Citation: Se. Berning et Ca. Peloquin, ADVERSE EVENTS ASSOCIATED WITH HIGH-DOSE RIFABUTIN IN MACROLIDE-CONTAINING REGIMENS FOR THE TREATMENT OF MYCOBACTERIUM-AVIUM COMPLEX LUNG-DISEASE, Clinical infectious diseases, 22(5), 1996, pp. 885-885
Authors:
BERNING SE
MADSEN L
ISEMAN MD
PELOQUIN CA
Citation: Se. Berning et al., LONG-TERM SAFETY OF OFLOXACIN AND CIPROFLOXACIN IN THE TREATMENT OF MYCOBACTERIAL INFECTIONS, American journal of respiratory and critical care medicine, 151(6), 1995, pp. 2006-2009
Authors:
ELLIOTT AM
BERNING SE
ISEMAN MD
PELOQUIN CA
Citation: Am. Elliott et al., FAILURE OF DRUG PENETRATION AND ACQUISITION OF DRUG-RESISTANCE IN CHRONIC TUBERCULOUS EMPYEMA, Tubercle and lung disease, 76(5), 1995, pp. 463-467